Methotrexate-associated lymphoproliferative disease with multiple pulmonary nodules in a patient with rheumatoid arthritis

BMJ Case Rep. 2017 Dec 1:2017:bcr2017221778. doi: 10.1136/bcr-2017-221778.

Abstract

A 62-year-old woman with rheumatoid arthritis and secondary Sjögren's syndrome took methotrexate (MTX) 5 mg three times a week regularly but gradually developed an intermittent fever, oral ulcers and productive cough with mucopurulent sputum for about 2 weeks. Image study found multiple nodular lesions and lymphadenopathies in bilateral lungs. Empirical antibiotics for 1 week failed to alleviate the fever. A transbronchial biopsy in the right fourth bronchus showed infiltration of abnormally enlarged lymphoid cells with a surface marker of CD20, some of which also stained positively in situ with Epstein-Barr virus-encoded small RNA and some CD3(+) cells. After a diagnosis of MTX-associated lymphoproliferative disease had been made, MTX was discontinued immediately and intravenous methylprednisolone 125 mg/day was given for 1 week. The clinical condition improved dramatically within 1 month and there was no recurrence after 3-year follow-up.

Keywords: musculoskeletal and joint disorders; pneumonia (respiratory medicine); radiology; rheumatoid arthritis.

Publication types

  • Case Reports

MeSH terms

  • Administration, Intravenous
  • Aftercare
  • Antigens, CD20 / metabolism
  • Antirheumatic Agents / adverse effects
  • Arthritis, Rheumatoid / complications
  • Arthritis, Rheumatoid / drug therapy*
  • Female
  • Glucocorticoids / therapeutic use
  • Humans
  • Lymphoproliferative Disorders / chemically induced*
  • Lymphoproliferative Disorders / metabolism
  • Lymphoproliferative Disorders / pathology
  • Methotrexate / adverse effects*
  • Methotrexate / therapeutic use
  • Methylprednisolone / administration & dosage
  • Methylprednisolone / therapeutic use
  • Middle Aged
  • Multiple Pulmonary Nodules / diagnostic imaging*
  • Multiple Pulmonary Nodules / pathology
  • Sjogren's Syndrome / complications
  • Sjogren's Syndrome / drug therapy*
  • Treatment Outcome

Substances

  • Antigens, CD20
  • Antirheumatic Agents
  • Glucocorticoids
  • Methylprednisolone
  • Methotrexate